Navigation Links
BUSM investigates cellular mechanisms leading to immune response in airway epithelium
Date:11/23/2010

(Boston) Researchers from the Boston University School of Medicine (BUSM) have demonstrated that commensal species of the genus Neisseriae are low inducers of human airway epithelial cell responses as compared to the pathogenic species. Specifically, the study indicates that a Neisserial outer membrane component appears to play a differential role in the host inflammatory responses via interaction with a receptor on the surface of human airway epithelial cells.

Paola Massari, an assistant professor in the section of infectious diseases at BUSM, is lead author of this study, which is published in the Dec. 2010 issue of the journal Infection and Immunity.

The team focused their research on Neisseria lactamica, a gram negative organism comprising both commensal and pathogenic bacteria. Neisseria meningitidis, the causative agent of meningococcal meningitis, as well as Neisseria lactamica, colonize the human nasopharynx, but only Neisseria meningitidis is pathogenic.

"We set out to understand the relationship between commensal Neisseriae organisms and the human hosts," said Massari. "Although Neisseriae organisms express mostly identical surface antigens and structures, they appear to induce different responses when they interact with the host."

To examine how the bacteria interact with human nasopharyngeal cells, Massari and her research team honed in on a bacterial surface component, the PorB porin, present in all Neisseriae organisms. After purifying the PorB, they found that the protein from the commensal bacteria induced lower levels of human airway epithelial cell activation compared to PorB purified from the pathogenic organisms.

Next, the team demonstrated that PorB from N. lactamica and PorB from N. meningitidis appear to interact with the host cell surface receptor, Toll-like receptor 2 (TLR2), in a differential manner, thus l
'/>"/>

Contact: Jenny Eriksen
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UI study investigates variability in mens recall of sexual cues
2. Thesis investigates characteristics of society using sports activities as research tool
3. Food Safety Law Firm Investigates Major Outbreak of E. coli Linked To Lettuce
4. Long Island Press Investigates Big Tobacco's Lobby to Kill Indian Cigarette Trade
5. Positive psychological changes from meditation training linked to cellular health
6. c-Met may be a biomarker for metastatic hepatocellular carcinoma
7. A potential chemotherapeutic drug to treat hepatocellular carcinoma
8. Linc-ing a noncoding RNA to a central cellular pathway
9. Turning back the cellular clock
10. Cellular South Renews As Official Partner Of 2010 St. Jude Classic
11. Human Extracellular Matrix Significantly Improves Device Biocompatibility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 31, 2015 , ... When responsible for the care of ... The questions race through your mind: What happens if mom falls? Who will remind ... and cancel your plans. , But not taking time away from caregiving responsibilities can ...
(Date:7/30/2015)... ... July 31, 2015 , ... Committed to helping the next generation succeed ... members to contribute to the College’s “My Brother’s Keeper Scholarship.” The President’s signature initiative ... on track. Providing the support they need to think more broadly about their future. ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide the ... is making a change in his practice. , The decision will also allow him ... Dr. Aggarwal will be transferring his in-patient admissions to the hospitalists at East Liverpool ...
(Date:7/30/2015)... ... July 30, 2015 , ... Eyepartner is ... victims in San Diego, California’s Gaslamp Quarter Plaza for five years this September. ... actively monitor the area for any suspicious activity. These cameras are in place ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... Biz Report, which takes a look at small, medium, and large businesses making ... business expert, conducted the business review and shared with viewers how DevExpress has ...
Breaking Medicine News(10 mins):Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 2Health News:Aging Life Care Association™ Experts Offer Tips for Caregivers in Need of Vacation Time 3Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2
... The first Eklin RapidStudy(TM),digital radiography (DR) system in ... Wellness Clinic which serves south central Pennsylvania,including Gettysburg, ... Medical Systems, the leader in veterinary care DR ... veterinary patients,supporting the Clinic,s commitment to excellent patient ...
... Fleishman to retire from BoardNATICK, Mass., March 2 Boston ... the Company,s Board of Directors has elected John E. Sununu ... Sununu served as a U.S. Senator from New Hampshire. ... Finance and Foreign Relations, and he was appointed the Congressional ...
... 1 Selling Prefilled Insulin Pen in the World Available ... 2 Novo Nordisk has ... in the world(1), to allow diabetes patients to use ... insulin and easily identify their insulin with prominent color ...
... and vegetarians most affected, study says , , MONDAY, March 2 (HealthDay ... their blood before and after conception have a greater chance of ... study says. , Most at risk may be vegans ... animal-based foods, noted an American and Irish research team whose findings ...
... about personal finances , , MONDAY, March 2 (HealthDay News) -- ... unable to get a good night,s sleep because they,re ... new poll finds. , Money woes far outweigh other ... warming, or the threat of a terrorist attack, according to ...
... Pays Cash When You Are Sick or Hurt?COLUMBUS, Ga., March 2 ... Aflac Duck as the mystery benefactor to policyholders who ... humorously shows how Aflac pays cash benefits when a medical ... night in a dark parlor. A group of friends is comforting ...
Cached Medicine News:Health News:Dr. Flake's Animal Wellness Clinic Installs Adams County's First Eklin Digital Radiography System 2Health News:Dr. Flake's Animal Wellness Clinic Installs Adams County's First Eklin Digital Radiography System 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 2Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 3Health News:Boston Scientific Announces Election Of John Sununu To Its Board Of Directors 4Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 2Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 3Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 4Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 5Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 6Health News:Photos: Novo Nordisk Improved FlexPen(R) Now Available in the U.S. 7Health News:B12 Deficit May Boost Risk of Birth Defects 2Health News:With the Economy Down, Sleeplessness Is Up 2Health News:With the Economy Down, Sleeplessness Is Up 3Health News:New Aflac Commercial Asks, 'Who Dun It?' 2Health News:New Aflac Commercial Asks, 'Who Dun It?' 3
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ... quarter of 2015. Key results include: , ... quarter of 2014 to $5,370 million, with 6 ... ® (etanercept), Prolia ® (denosumab), Sensipar ... XGEVA ® (denosumab). Unfavorable changes in foreign ...
(Date:7/30/2015)... 2015 Eisai Inc. announced today that regulatory ... States , European Union and Japan ... for eribulin, for the treatment of patients with inoperable ... for advanced or metastatic disease. These ... global Phase 3 clinical trial (Study 309), which met ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... (Nasdaq: DCTH ) will host a live webcast ... meeting on May 23, 2012 at 10:00 a.m ET at ... commence at approximately 10:15 a.m ET. To listen ... during or after the event, please visit the Investor Relations ...
... May 21, 2012 InfuSystem Holdings, Inc. (NYSE MKT: ... infusion pumps and related services, today announced that it ... notification to NYSE Amex of the "record date" for ... April 30, 2012 the record date for the Company,s ...
Cached Medicine Technology:Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders 2Delcath to Webcast Management's Presentation at Annual Meeting of Stockholders 3InfuSystem Holdings, Inc. Receives Letter From NYSE MKT Regarding Timely Notice Of Record Date For 2012 Annual Meeting Of Stockholders 2
The Storz Premiere comes as anterior, posterior and anterior/posterior combo. The combo provides the following modes irrigation, irrigation/aspiration, vitrectomy, and illumination....
Multiple Modulation Phaco (MMP) programmability with eight surgeon settings for maximum versatility. The combination of the peristaltic power balanced pump and the piezoelectric handpiece results in ...
Phaco-emulsification systems CV series...
... The SIStem (Solutions ... departs from the traditional. ... perspectives in phaco, with ... totally unique fluidics module, ...
Medicine Products: